Skip to main content
PMC home page
ESMO Open logoLink to ESMO Open
. 2021 Jun 8;6(4):100177. doi: 10.1016/j.esmoop.2021.100177

Erratum to ‘Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial’

[ESMO Open Volume 6, Issue 3, June 2021, 100101]

TK Choueiri 1,∗, J Larkin 2, S Pal 3, RJ Motzer 4, BI Rini 5, B Venugopal 6, B Alekseev 7, H Miyake 8, G Gravis 9, MA Bilen 10, S Hariharan 11, A Chudnovsky 12, KA Ching 13, XJ Mu 13, M Mariani 14, PB Robbins 15, B Huang 16, A di Pietro 14, L Albiges 17
PMCID: PMC8411062  PMID: 34474809

The publisher regrets that some minor corrections to punctuation were missed in the typesetting process. In addition, Figure 3C was incorrect when the article was published. All corrections have now been applied to the article and the figure corrected. The corrected Figure 3C also appears below:

graphic file with name gr1.jpg

Open in a new tab

The publisher would like to apologise for any inconvenience caused.

RESOURCES